Search Thermo Fisher Scientific
Quilizumab is under investigation in clinical trial NCT01160861 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis).
47H4; M1 prime; MEMP1972A; RG-7449
100 µg